BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

BioPharm Asia, Inc. Announces Approval of 15c2-11 Filing and Anticipates OTCBB Listing


12/18/2012 8:49:02 AM

TONGHUA, CHINA--(Marketwire - December 18, 2012) - Biopharm Asia, Inc. (PINKSHEETS: BFAR) is pleased to announce that Biopharm Asia, Inc. received approval for the recently submitted 15c2-11 filing late on Friday Dec 14th.

The Company will now seek listing with the OTC Bulletin Board at the earliest possible opportunity.

This is a significant step in the growth and development of Biopharm Asia, Inc. The approval and the subsequent OTC listing will allow the company to access additional capital market and investors through new merger and acquisition targets. Biopharm Asia is excited to continue its commitment to increasing transparency, exposure and providing liquidity for its shareholders.

Safe Harbor
The information in this release includes forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. These forward-looking statements, specifically statements relating to listing and trading on the OTCBB, contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Biopharm Asia to be materially different from the statements made herein. Although the Company believes that its expectations are based on reasonable assumptions, actual results may differ materially.


Contact Information
Contact:
Biopharm Asia, Inc
Investor Relations
(86)130-2919-4689



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->